Related Experiment Video
Updated: Mar 15, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Neglected tropical diseases: progress towards addressing the chronic pandemic
David H Molyneux1, Lorenzo Savioli2, Dirk Engels3
1Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, UK.
Neglected tropical diseases (NTDs) affect the poorest populations, with significant progress made in control and elimination efforts. However, challenges like weak health systems hinder further scaling up and achieving global targets.
Area of Science:
- Global Health
- Tropical Medicine
- Public Health Policy
Background:
- Neglected tropical diseases (NTDs) disproportionately affect impoverished populations globally.
- Over a decade of recognition has led to policy momentum and progress in NTD control and elimination.
- Sustained support from various organizations and pharmaceutical donations have been crucial.
Purpose of the Study:
- To review the progress and challenges in the control and elimination of neglected tropical diseases.
- To highlight the inclusion of NTDs in global health agendas like the Sustainable Development Goals.
- To identify research needs for affordable diagnostics, drugs, and insecticides.
Main Methods:
- The study is a review of the concept and progress of neglected tropical diseases.
- It synthesizes information on policy development, global targets, and reported achievements.
- Analysis of challenges hindering further progress is included.
Main Results:
- Over 1 billion people benefited from preventive chemotherapy in 2014, indicating substantial progress.
- The World Health Organization's (WHO) Roadmap and Sustainable Development Goals address NTDs.
- Affordable products are identified as a key research need.
Conclusions:
- Despite significant achievements in NTD control, substantial challenges remain.
- Insecurity and weak health systems in low-income countries impede scaling up interventions.
- Continued efforts are needed to achieve global NTD elimination goals and ensure universal health coverage.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-I: Introduction
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...

